Cytomegalic Inclusion Disease - 21 Studies Found Completed : Valganciclovir for Treatment of Cytomegalovirus Infection in Solid Organ Transplant Patients : Cytomegalovirus Infection : 2008-08-05 : Drug: Single arm (ganciclovir and valganciclovir) Patients received a short induction of IV ganciclovir Terminated : Trial of Preemptive Treatment With Oral Valganciclovir Compared With Intravenous (IV) Ganciclovir for Cytomegalovirus Infection After Bone Marrow or Peripheral Blood Stem Cell Transplant : Cytomegalovirus Infections : 2005-10-17 : Drug: Valganciclovir Drug: Ganciclovir Recruiting : Analysis of CMV Infections in Patients With Brain Tumors or Brain Metastases During and After Radio(Chemo)Therapy : Cytomegalovirus Infections : 2015-10-23 : Other: Blood draw and MRI The study is observational. The treatment-plan of the underlying disease remai Recruiting : Conversion to Sirolimus: Effects in Cytomegalovirus Infection Recurrence : Cytomegalovirus Infections : 2016-01-26 : Drug: Drug conversion to sirolimus Completed : Clinical Evaluation of Ultrashort-term Heat Inactivation of Cytomegalovirus (CMV) Containing Raw Breast Milk to Prevent CMV-infection of Preterm Infants : Cytomegalovirus Infection Preterm Infants : 2010-07-26 : Procedure: ultrashort heat inactivation Recruiting : CMV-CTL for the Treatment of CMV Infection After HSCT : Cytomegalovirus Infections Hematological Disease : 2016-12-18 : Biological: CMV-CTL donor deri Completed : A Pharmacokinetic and Tolerance Study of Oral Ganciclovir in HIV-Infected Children With Asymptomatic Cytomegalovirus Infection and Low CD4 Cell Counts or Quiescent Cytomegalovirus Disease : Cytomegalovirus Infections HIV Infections : 1999-11-02 : Drug: Ganciclovir Completed : IMPACT Study: A Study of Valcyte (Valganciclovir) for Prevention of Cytomegalovirus Disease (CMV) in Kidney Allograft Recipients : Cytomegalovirus Infections : 2006-02-21 : Drug: Valganciclovir 900 mg or Recruiting : Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporineversus an Immunosuppressive Regimen With Mycophenolic Acid and Standard Dose of Cyclosporine A : Transplantation Infection Cytomegalovirus Infection : 2014-09-01 : Drug: Everolimus Terminated : Prediction of Cytomegalovirus (CMV) Reactivation in Intensive Care Unit (ICU) by Immunological Study : CMV Infection : 2016-03-23 <<< Previous | Next >>>
